🔎 Trials Near Me

Beranda › Degenerasi Makula › Massachusetts

Uji klinis Degenerasi Makula di Massachusetts

14 studi untuk Degenerasi Makula mencari peserta di lokasi di Massachusetts.

Kota di Massachusetts

Teks studi resmi (Bahasa Inggris)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Ophthalmic Consultants of Boston, Boston
Menerima pesertaFase 2/3
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06635148

A Study in Adults With Geographic Atrophy

  • Ophthalmic Consultants of Boston, Waltham
Menerima pesertaFase 2
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07606365

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  • Massachusetts Eye And Ear Infirmary, Boston
  • Opthalmic Consultants of Boston, Boston
  • New England Retina Consultants, PC, Springfield
  • dan 2 lainnya
Menerima pesertaFase 3
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06541704

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • Retina Research Institute at New England Retina Consultants, Springfield
Menerima pesertaFase 2
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06659445

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • Ophthalmic Consultants of Boston, Boston
Menerima pesertaFase 1
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT03178149

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

  • Ophthalmic Consultants of Boston, Boston
Menerima pesertaStudi observasional
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06346600

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

  • Ophthalmic Consultants of Boston & Boston Eye Surgery and Laser Center, Boston
Menerima pesertaFase 1/2
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT05197270

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

  • Retina Research Institute at New England Retina Consultants, PC, Springfield
Menerima pesertaFase 2/3
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07496567

Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

  • Ophthalmic Consultants of Boston, East Weymouth
Menerima pesertaFase 1
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT07230834

The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma

  • MCPHS 10 Lincoln Square, Worcester
Menerima pesertaFase awal 1Sukarelawan sehat diterima
Usia 50 hingga 100 · Semua jenis kelamin · Diperbarui 12 Mei 2026 · NCT06593405

Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss

  • New England College of Optometry, Boston
Menerima peserta
Usia 14 ke atas · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT07577219

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  • New England Retina Consultants, Springfield
Menerima pesertaFase 3
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT07064759

Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD

  • Massachusetts Eye and Ear Infirmary, Boston
Menerima pesertaFase 2
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 26 Jan 2026 · NCT04735263

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

  • Tallman Eye Associates, Lawrence
Menerima peserta
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 3 Des 2024 · NCT05438732

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.